BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 17998832)

  • 1. A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software.
    Firouzi F; Rashidi M; Hashemi S; Kangavari M; Bahari A; Daryani NE; Emam MM; Naderi N; Shalmani HM; Farnood A; Zali M
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1075-81. PubMed ID: 17998832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
    Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases].
    Ben Hamida KS; Serghini M; Ksontini I; Kedadi H; Ben Yaghléne L; Bougassas W; Dougui MH
    Tunis Med; 2009 Feb; 87(2):144-8. PubMed ID: 19522449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
    von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
    Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
    Vestergaard P
    Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal morbidity in inflammatory bowel disease.
    van Hogezand RA; Hamdy NA
    Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
    Bernstein CN; Seeger LL; Sayre JW; Anton PA; Artinian L; Shanahan F
    J Bone Miner Res; 1995 Feb; 10(2):250-6. PubMed ID: 7754804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: Osteoporosis and inflammatory bowel disease.
    Bernstein CN; Leslie WD
    Aliment Pharmacol Ther; 2004 May; 19(9):941-52. PubMed ID: 15113361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteodensitometry in children and adolescents with inflammatory bowel disease].
    Kluge G; Borte M; Richter T; Kahn T; Borte G
    Rofo; 2007 Jan; 179(1):58-64. PubMed ID: 17203445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease.
    Heijckmann AC; Huijberts MS; Schoon EJ; Geusens P; de Vries J; Menheere PP; van der Veer E; Wolffenbuttel BH; Stockbrugger RW; Dumitrescu B; Nieuwenhuijzen Kruseman AC
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):740-7. PubMed ID: 18617778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease.
    Tan B; Li P; Lv H; Li Y; Wang O; Xing XP; Qian JM
    J Dig Dis; 2014 Mar; 15(3):116-23. PubMed ID: 24354597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients].
    Boubaker J; Feki M; Hsairi M; Fekih M; Kaabachi N; Filali A; Mebazaa A
    Gastroenterol Clin Biol; 2003 Oct; 27(10):901-7. PubMed ID: 14631305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Osteoporosis associated with inflammatory bowel diseases].
    Miheller P; Tóth M; Pregun I; Tulassay Z
    Orv Hetil; 2004 May; 145(20):1045-51. PubMed ID: 15202326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease.
    Henderson S; Hoffman N; Prince R
    Am J Gastroenterol; 2006 Jan; 101(1):119-23. PubMed ID: 16405543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone metabolism in 53 children and adolescents with chronic inflammatory bowel disease].
    Scheer K; Kratzsch J; Deutscher J; Gelbrich G; Borte G; Kiess W
    Klin Padiatr; 2004; 216(2):62-6. PubMed ID: 15106075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation.
    Vogelsang H; Ferenci P; Resch H; Kiss A; Gangl A
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):609-14. PubMed ID: 8590154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density in patients with inflammatory bowel disease from north-eastern Romania.
    Dumitrescu G; Mihai C; Dranga M; Prelipcean CC
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(1):23-8. PubMed ID: 24505888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered bone metabolism in inflammatory bowel disease.
    Bischoff SC; Herrmann A; Göke M; Manns MP; von zur Mühlen A; Brabant G
    Am J Gastroenterol; 1997 Jul; 92(7):1157-63. PubMed ID: 9219790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of osteoporosis in inflammatory bowel disease.
    Reinshagen M; Von Tirpitz C
    Minerva Med; 2004 Dec; 95(6):481-7. PubMed ID: 15785433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low bone mineral density in children with Crohn's disease].
    Bourges O; Dorgeret S; Alberti C; Hugot JP; Sebag G; Cézard JP
    Arch Pediatr; 2004 Jul; 11(7):800-6. PubMed ID: 15234375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.